Zhejiang Hisoar Pharmaceutical Co.,LTD. (2099) - Financial and Strategic Analysis ReviewZhejiang Hisoar Pharmaceutical Co.,LTD. (Hisoar), a public share holding company is engaged in the production and sale of drug substances and drug intermediates. The company principally operates in China and also has global presence offering various active pharmaceutical ingredients and intermediates for human as well as veterinary. Hisoar's range of products...more
PT. Pyridam Farma Tbk. (PYFA) - Financial and Strategic Analysis ReviewPT. Pyridam Farma Tbk. (Pyridam) is a pharmaceutical company engaged in the manufacture of cosmetics, food supplements, over the counter (OTC) and prescription drugs. The pharmaceutical formulations of the company are manufactured in the form of tablets, caplets, capsules, syrups, creams and ointment. It also produces prescription drugs such as penicillin and non-penicillin...more
SemBiosys Genetics Inc. (SBS) - Financial and Strategic Analysis ReviewSemBioSys Genetics Inc. (SemBioSys) is a palnt biotechnology company, that is engaged in the development of pharmaceutical and non-pharmaceutical products to treat various disorders. The company is focused on the development of cost effective production solution targeting diabetes and cardiovascular diseases. The product insulin is used for diabetes and Apo AIMilano for cardiovascular disease. It operates under two reportable segments namely biopharmaceuticals and bioproducts and specialty products. The company is also engaged in the application of technology to the agricultural biotechnology products and nutritional supplements.This comprehensive SWOT profile of SemBiosys Genetics Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of...more
Pharmesis International Ltd. (P31) - Financial and Strategic Analysis ReviewPharmesis International Ltd. (Pharmesis) is a pharmaceutical company that manufactures western medicine and traditional Chinese medicine principally for the treatment of liver and gall bladder disorders. The company is also focused on the research and development,...more
Zhejiang Hisun Pharmaceutical Co. Ltd. (600267) - Financial and Strategic Analysis ReviewZhejiang Hisun Pharmaceutical Co. Ltd. (Hisun), a China-based public share holding company is engaged in the manufacture and sale of bulk drugs. It principally focuses in providing drugs used in antineoplastics, cardiovascular treatment, anti-infection,...more
Zhejiang Jingxin Pharmaceutical Co., Ltd (2020) - Financial and Strategic Analysis ReviewZhejiang Jingxin Pharmaceutical Co., Ltd (Jingxin Pharma), formerly known as Zhejiang Jingxin Pharmaceutical Factory is a China-based public share holding company. The company focuses on manufacture and sale of raw materials of chemical drugs, chemical preparations and Chinese herbal preparations. It offers quinolone drugs, cephalosporin drugs, drugs for cardio-cerebral-vascular diseases, traditional Chinese herbal medicines and other drugs.This comprehensive SWOT profile of Zhejiang Jingxin Pharmaceutical Co., Ltd provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.This company report forms part of the Profile on Demand service, covering over 50,000 of the worlds leading companies. Once purchased, the highly qualified team of company analysts will...more
Tianjin Tasly Pharmaceutical Co., Ltd. (600535) - Financial and Strategic Analysis ReviewTianjin Tasly Pharmaceutical Co. Ltd. (Tasly) is a pharmaceutical company engaged in the development, manufacturing and distribution of chemical medicine,...more
Suven Life Sciences Ltd. (530239) - Financial and Strategic Analysis ReviewSuven Life Sciences Ltd. (Suven) is a biotechnology company engaged in the business of design, manufacture and supply of bulk actives, drug intermediates and fine chemicals,...more
Welichem Biotech Inc. (WBI) - Financial and Strategic Analysis ReviewWelichem Biotech Inc. (Welichem, formerly known as Welichem Technology Corporation) is a public share holding company. It is principally engaged in the discovery, research and...more
Adeona Pharmaceuticals, Inc. (AEN) - Financial and Strategic Analysis ReviewAdeona Pharmaceuticals, Inc. (Adeona), public shareholding company is a development-stage specialty pharmaceutical company. It principally focuses on the treatment of...more
Tianjin Zhongxin Pharmaceutical Group Corporation Limited (T14) - Financial and Strategic Analysis ReviewTianjin Zhongxin Pharmaceutical Group Corporation Limited (TZPG) is a pharmaceutical company, engaged in the production and sale of Chinese...more
Pharmstandard (PHST) - Financial and Strategic Analysis ReviewPharmstandard is engaged in the manufacture and marketing of pharmaceuticals and medical products. It operates in two segments namely; pharmaceuticals products and medical equipment. Its...more